Rath W - Search Results

1

Multifactorial analysis of affinity-mass spectrometry data from serum protein samples: a strategy to distinguish patients with preeclampsia from matching control individuals.

Pecks U, Seidenspinner F, Röwer C, Reimer T, Rath W, Glocker MO. Pecks U, et al. Among authors: rath w. J Am Soc Mass Spectrom. 2010 Oct;21(10):1699-711. doi: 10.1016/j.jasms.2009.12.013. Epub 2010 Jan 4. J Am Soc Mass Spectrom. 2010. PMID: 20116281 Free article.

2

Comparison of blood serum protein analysis by MALDI-MS from either conventional frozen samples or storage disc-deposited samples: A study with human serum from pregnant donors and from patients with intrauterine growth restriction.

Wölter M, Russ M, Okai CA, Rath W, Pecks U, Glocker MO. Wölter M, et al. Among authors: rath w. Eur J Mass Spectrom (Chichester). 2019 Aug;25(4):381-390. doi: 10.1177/1469066718820991. Epub 2018 Dec 26. Eur J Mass Spectrom (Chichester). 2019. PMID: 30587036

3

Maternal Apolipoprotein B100 Serum Levels are Diminished in Pregnancies with Intrauterine Growth Restriction and Differentiate from Controls.

Wölter M, Okai CA, Smith DS, Ruß M, Rath W, Pecks U, Borchers CH, Glocker MO. Wölter M, et al. Among authors: rath w. Proteomics Clin Appl. 2018 Nov;12(6):e1800017. doi: 10.1002/prca.201800017. Epub 2018 Jul 23. Proteomics Clin Appl. 2018. PMID: 29956482

4

A proteome signature for intrauterine growth restriction derived from multifactorial analysis of mass spectrometry-based cord blood serum profiling.

Wölter M, Röwer C, Koy C, Reimer T, Rath W, Pecks U, Glocker MO. Wölter M, et al. Among authors: rath w. Electrophoresis. 2012 Jul;33(12):1881-93. doi: 10.1002/elps.201200001. Electrophoresis. 2012. PMID: 22740482

5

Mass spectrometric profiling of cord blood serum proteomes to distinguish infants with intrauterine growth restriction from those who are small for gestational age and from control individuals.

Pecks U, Kirschner I, Wölter M, Schlembach D, Koy C, Rath W, Glocker MO. Pecks U, et al. Among authors: rath w. Transl Res. 2014 Jul;164(1):57-69. doi: 10.1016/j.trsl.2013.12.003. Epub 2013 Dec 10. Transl Res. 2014. PMID: 24373862

6

Apparent systemic 11ß-dehydroxysteroid dehydrogenase 2 activity is increased in preeclampsia but not in intrauterine growth restriction.

Vasku M, Kleine-Eggebrecht N, Rath W, Mohaupt MG, Escher G, Pecks U. Vasku M, et al. Among authors: rath w. Pregnancy Hypertens. 2018 Jan;11:7-11. doi: 10.1016/j.preghy.2017.11.012. Epub 2017 Dec 6. Pregnancy Hypertens. 2018. PMID: 29523277

7

Hemorheological changes in women with severe preeclampsia.

Heilmann L, Rath W, Pollow K. Heilmann L, et al. Among authors: rath w. Clin Hemorheol Microcirc. 2004;31(1):49-58. Clin Hemorheol Microcirc. 2004. PMID: 15272153

8

BMI: new aspects of a classical risk factor for hypertensive disorders in pregnancy.

Leeners B, Rath W, Kuse S, Irawan C, Imthurn B, Neumaier-Wagner P. Leeners B, et al. Among authors: rath w. Clin Sci (Lond). 2006 Jul;111(1):81-6. doi: 10.1042/CS20060015. Clin Sci (Lond). 2006. PMID: 16579791

9

New Insights into the Pathogenesis of Preeclampsia - The Role of Nrf2 Activators and their Potential Therapeutic Impact.

Kweider N, Wruck CJ, Rath W. Kweider N, et al. Among authors: rath w. Geburtshilfe Frauenheilkd. 2013 Dec;73(12):1236-1240. doi: 10.1055/s-0033-1360133. Geburtshilfe Frauenheilkd. 2013. PMID: 24771904 Free PMC article.

10

Neonatal platelet activation in preeclampsia.

Klein B, Faridi A, Amo-Takyi BK, Heilmann L, Von Tempelhoff GF, Rath W. Klein B, et al. Among authors: rath w. Clin Appl Thromb Hemost. 2001 Jan;7(1):29-32. doi: 10.1177/107602960100700107. Clin Appl Thromb Hemost. 2001. PMID: 11190901 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results